Zhejiang DIAN Diagnostics Co., Ltd. signed an equity transfer agreement to acquire Hangzhou Dege Medical Equipment Co., Ltd. from Hangzhou Digui Equity Investment Management Partnership Enterprise (Limited Partnership) and Chen Zuoxiu for approximately CNY 320 million.
November 17, 2016
Share
Zhejiang DIAN Diagnostics Co., Ltd. (SZSE:300244) signed an equity transfer agreement to acquire Hangzhou Dege Medical Equipment Co., Ltd. from Hangzhou Digui Equity Investment Management Partnership Enterprise (Limited Partnership) and Chen Zuoxiu for approximately CNY 320 million on November 18, 2016. Under the terms of the transaction, Zhejiang DIAN Diagnostics Co., Ltd. will pay CNY 287.1 million to Hangzhou Digui Equity Investment Management Partnership Enterprise (Limited Partnership) for 90% stake and will pay CNY 29 million to Chen Zuoxiu for 10% stake. The transaction will be funded by self-raised funds of CNY 316.1 million by Zhejiang DIAN Diagnostics Co., Ltd. For the year ended December 31, 2015, Hangzhou Dege Medical Equipment Co., Ltd. had revenues of CNY 162.1 million, total assets of CNY 68.8 million, owners' equity of CNY 30.1 million and net profit of CNY 15.2 million. The transaction requires the approval from stockholders of Zhejiang DIAN Diagnostics Co., Ltd. The transaction was approved by the Board of Directors of Zhejiang DIAN Diagnostics Co., Ltd.
Dean Diagnostic Technology Group Co., Ltd. is a company providing integrated solutions for medical diagnosis. The Company's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The Company's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The Company's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.
Zhejiang DIAN Diagnostics Co., Ltd. signed an equity transfer agreement to acquire Hangzhou Dege Medical Equipment Co., Ltd. from Hangzhou Digui Equity Investment Management Partnership Enterprise (Limited Partnership) and Chen Zuoxiu for approximately CNY 320 million.
DIAN DIAGNOSTICS GROUP CO.,LTD. 
